We would love to hear your thoughts about our site and services, please take our survey here.
Agree Crl123, the pattern is indicative of some sort of placing being worked/coming, should really have done around March just after the 0518 news. The finance director needs to earn his corn- not impressed with his early performance.
At the end of the day buys and sells have to cancel out, so 50% of the trades are buys and another 50% sells. The only conclusion one can come to from the trades and volumes over the past few days is mm's are sat on large number of shares that they are willing to sell at a minimum price around 30p. Where those share have come from is a mystery that is open to a speculation.
Agree with crl123, BOD need to clarify why they need to have 100% authority, in any case, pre-emption rights are the only safeguards we PI's have and only be given if the BoD has made an attempt to justify this need. If any needed for negotiations should be bought from the open market.
some sizeable after-hours trades, not sure what to make of them, whether sells or buys but absorbed under 34p. lets see how the story unfolds from next Monday.
good volume trading going on, being kept in a tight range, not sure but seems to be transferring between related parties.
After hours sells is that the final clear out by the seller? we have to see in the next few days.
Echo SL's comments, thanks porks, much appreciated.
SR thanks, won’t be able to access it live @that time, would appreciate if someone could mention any salient points through this Bb.
Can someone post a link to the H.C. Wainwright presentation taking place today.
I'd be content with a ten-bagger from here. Done my final top-up, and expect some substantive rns before the Wainwright presentation.
JR- Thanks (trust you are still a good wicket-keeper).
So in essence, if it's newsworthy it may be rns'd Monday morning.
Does anyone know which day 4D is presenting their data for the study?
CP- wasn't implying that price-sensitive information had been leaked, merely speculating on the price volatility, perhaps due to people becoming aware of the data sets being made public at the ATS forum in the next 7 days beginning from today. Who knows they might drop an rns within this time frame if the results a good or price sensitive enough- one can but speculate on the positive side.
Do I smell positive data sets from the phase I/II Part A Asthma Study to be presented @ the ATS starting today.
They raised $39.8m Private placement- read the paragraph above Oxford finance. believe what you want, either trust the management or not, but don't obfuscate issues to suit your personal agenda.
Are you refuting the latest statement on this matter in the latest rns?
So when Duncan mentions initial draw dawn of $12.5m he is telling a lie in an rns that has been verified by the Nomad?
4D is presenting data from the asthma phase1/2 Part A study at the American Thoracic Society beginning on the 13th of May.